Published in Ann Neurol on May 01, 2001
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect (2007) 3.03
Motor coordination in autism spectrum disorders: a synthesis and meta-analysis. J Autism Dev Disord (2010) 2.51
Elevated immune response in the brain of autistic patients. J Neuroimmunol (2009) 2.46
Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J Clin Invest (2007) 2.45
Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures. Neurology (2010) 2.10
Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci (2013) 1.86
Behavioral profiles of affected and unaffected siblings of children with autism: contribution of measures of mother-infant interaction and nonverbal communication. J Autism Dev Disord (2011) 1.53
Prenatal treatment prevents learning deficit in Down syndrome model. PLoS One (2012) 1.41
Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms. Behav Neurol (2016) 1.40
A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism. Biol Psychiatry (2009) 1.33
Serum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents. J Clin Endocrinol Metab (2006) 1.14
Autism: an emerging public health problem. Public Health Rep (2003) 1.12
Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. J Neurodev Disord (2009) 1.10
Growth of head circumference in autistic infants during the first year of life. J Autism Dev Disord (2007) 1.09
Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation (2012) 1.04
Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One (2011) 1.01
Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation (2010) 1.01
Identification and characterization of two novel JARID1C mutations: suggestion of an emerging genotype-phenotype correlation. Eur J Hum Genet (2009) 0.99
Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med (2008) 0.98
A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry (2012) 0.97
A functional polymorphism of the brain derived neurotrophic factor gene and cortical anatomy in autism spectrum disorder. J Neurodev Disord (2009) 0.96
Early pharmacological treatment of autism: a rationale for developmental treatment. Biol Psychiatry (2007) 0.95
Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice. Exp Neurol (2008) 0.95
Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study. Autism Res (2008) 0.93
Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism. J Neuropathol Exp Neurol (2012) 0.92
Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediators Inflamm (2015) 0.91
BDNF stimulation of protein synthesis in cortical neurons requires the MAP kinase-interacting kinase MNK1. J Neurosci (2015) 0.91
The power and promise of identifying autism early: insights from the search for clinical and biological markers. Ann Clin Psychiatry (2009) 0.90
DIA1R is an X-linked gene related to Deleted In Autism-1. PLoS One (2011) 0.90
Immune therapy in autism: historical experience and future directions with immunomodulatory therapy. Neurotherapeutics (2010) 0.88
Increased BDNF expression in fetal brain in the valproic acid model of autism. Mol Cell Neurosci (2014) 0.86
Attitudes about the use of newborn dried blood spots for research: a survey of underrepresented parents. Acad Pediatr (2013) 0.86
Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder. J Neural Transm (Vienna) (2014) 0.85
Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatr (2003) 0.85
Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome. Front Cell Neurosci (2014) 0.84
Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec (Hoboken) (2011) 0.84
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry (2013) 0.84
Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray. Int J Mol Sci (2009) 0.83
The nerve growth factor signaling and its potential as therapeutic target for glaucoma. Biomed Res Int (2014) 0.83
QTL replication and targeted association highlight the nerve growth factor gene for nonverbal communication deficits in autism spectrum disorders. Mol Psychiatry (2011) 0.82
Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci (2009) 0.82
Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior. Int J Dev Neurosci (2008) 0.81
Brief report: a preliminary study of fetal head circumference growth in autism spectrum disorder. J Autism Dev Disord (2011) 0.81
Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism. Cell Mol Neurobiol (2004) 0.81
High complement factor I activity in the plasma of children with autism spectrum disorders. Autism Res Treat (2011) 0.80
Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients. Mol Brain (2014) 0.79
Serum nerve growth factor levels in autistic children in Turkish population: a preliminary study. Indian J Med Res (2013) 0.79
Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue. Sci Rep (2016) 0.79
Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol (2014) 0.79
Neurotrophin blood-based gene expression and social cognition analysis in patients with autism spectrum disorder. Neurogenetics (2014) 0.78
Larger brains in medication naive high-functioning subjects with pervasive developmental disorder. J Autism Dev Disord (2004) 0.78
Levels of serum brain-derived neurotrophic factor in primates. Primates (2003) 0.77
Peripheral brain-derived neurotrophic factor in autism spectrum disorder: a systematic review and meta-analysis. Sci Rep (2016) 0.76
Sera from children with autism induce autistic features which can be rescued with a CNTF small peptide mimetic in rats. PLoS One (2015) 0.76
Proposed toxic and hypoxic impairment of a brainstem locus in autism. Int J Environ Res Public Health (2013) 0.76
Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist. Psychopharmacology (Berl) (2015) 0.76
Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. CNS Neurol Disord Drug Targets (2010) 0.76
Association of peripheral BDNF level with cognition, attention and behavior in preschool children. Child Adolesc Psychiatry Ment Health (2016) 0.76
Postoperative cerebellar mutism and autistic spectrum disorder. Childs Nerv Syst (2010) 0.75
Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism (2016) 0.75
Riluzole stimulates BDNF release from human platelets. Biomed Res Int (2015) 0.75
Study of the serotonin transporter (SLC6A4) and BDNF genes in French patients with non syndromic mental deficiency. BMC Med Genet (2010) 0.75
Bergmann Glia, Long-Term Depression, and Autism Spectrum Disorder. Mol Neurobiol (2016) 0.75
Polymorphisms of BDNF gene and autism spectrum disorders: family based association study with korean trios. Psychiatry Investig (2014) 0.75
Delineating the Common Biological Pathways Perturbed by ASD's Genetic Etiology: Lessons from Network-Based Studies. Int J Mol Sci (2017) 0.75
Pilot Study and Review: Physiological Differences in BDNF, a Potential Biomarker in Males and Females with Autistic Disorder. Int Neuropsychiatr Dis J (2014) 0.75
Brain-Derived Neurotrophic Factor Levels in Autism: A Systematic Review and Meta-Analysis. J Autism Dev Disord (2017) 0.75
The Emergence of Network Inefficiencies in Infants With Autism Spectrum Disorder. Biol Psychiatry (2017) 0.75
Meta-Analysis of BDNF Levels in Autism. Cell Mol Neurobiol (2016) 0.75
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med (1991) 6.09
Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med (1996) 3.74
A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med (1993) 3.74
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics (1995) 2.85
Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med (1995) 2.39
Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet (1971) 2.22
Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20
Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92
Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med (1992) 1.90
Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight. Am J Obstet Gynecol (1998) 1.86
Immunologic function and survival in hemodialysis patients. Kidney Int (1998) 1.82
Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol (1998) 1.80
The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer (1972) 1.75
An assessment of error in parental occupation from the birth certificate. Am J Epidemiol (1990) 1.58
Infarcts with a cardiac source of embolism in the NINCDS Stroke Data Bank: historical features. Neurology (1990) 1.58
Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res (1996) 1.53
Circulating immune complexes in schistosomiasis due to Schistosoma mansoni. Br Med J (1975) 1.51
Presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours. Clin Endocrinol (Oxf) (1993) 1.49
Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry (2013) 1.46
Abnormalities of spatial discrimination in focal and generalized dystonia. Brain (2003) 1.43
Evaluation of the hospital discharge diagnoses index and the birth certificate as sources of information on birth defects. Public Health Rep (1990) 1.41
A clinical staging classification for type C Niemann-Pick disease. Neurology (1992) 1.40
Congenital abnormalities among children with cerebral palsy: More evidence for prenatal antecedents. J Pediatr (2001) 1.40
The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol (1990) 1.34
Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics (1995) 1.29
Sudden infant death syndrome among Asians in California. J Pediatr (1990) 1.25
Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO. FEBS Lett (1987) 1.23
Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology (1998) 1.22
Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem (1992) 1.18
Isolated oral cleft malformations: associations with maternal and infant characteristics in a California population. Teratology (1991) 1.17
Phospholipid molecular species alterations in microsomal membranes as an initial key step during cellular acclimation to low temperature. Biochemistry (1982) 1.16
Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun (2005) 1.16
Causes of cerebral palsy. Curr Opin Pediatr (1999) 1.15
Herpes simplex type 2 encephalitis concurrent with known cerebral metastases. Acta Neuropathol (1979) 1.13
Assessment of gestational age using birth certificate data compared with medical record data. Paediatr Perinat Epidemiol (1997) 1.11
Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production. Free Radic Biol Med (1987) 1.10
Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies. J Cutan Pathol (1979) 1.10
Visual recognition memory in drug-exposed infants. J Dev Behav Pediatr (1992) 1.10
Rapid membrane response during low-temperature acclimation. Correlation of early changes in the physical properties and lipid composition of Tetrahymena microsomal membranes. Biochim Biophys Acta (1981) 1.10
Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease. Ann Neurol (1997) 1.09
Accelerometry to distinguish psychogenic from essential or parkinsonian tremor. Neurology (2003) 1.08
Cerebral palsy in four northern California counties, births 1983 through 1985. J Pediatr (1993) 1.06
Exposure to aerial malathion application and the occurrence of congenital anomalies and low birthweight. Am J Public Health (1987) 1.06
Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota. Ann Neurol (1987) 1.04
Kinematic characteristics of standing disequilibrium: reliability and validity of a posturographic protocol. Arch Phys Med Rehabil (1999) 1.03
Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J Am Soc Nephrol (2000) 1.03
Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine (2001) 1.02
Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol (1992) 1.02
The epidemiology of mental retardation of unknown cause. Pediatrics (2001) 1.00
Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls. Am J Dis Child (1989) 0.99
Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnes Res (1996) 0.99
Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res (1994) 0.98
Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions. Am J Pathol (1990) 0.98
Microvascular assessment of burn depth conversion during varying resuscitation conditions. J Burn Care Rehabil (2001) 0.97
HIV-associated immune-mediated renal disease. Kidney Int (1993) 0.97
Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss. Am J Physiol (1996) 0.97
Peptidoglycan synthesis and turnover in cell division mutants of Agmenellum. J Bacteriol (1976) 0.95
Stereoselective reduction of pyruvate by sodium borohydride catalyzed by pyruvate kinase. Biochim Biophys Acta (1973) 0.95
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol (1985) 0.95
Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol (1973) 0.94
Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem (1994) 0.94
A system of immunofluorescence in the study of tumour cells. Rev Eur Etud Clin Biol (1970) 0.93
Protective effect of cyclohexyl adenosine in treatment of cerebral ischemia in gerbils. Neuroscience (1989) 0.93
Comparison of pergolide and bromocriptine therapy in parkinsonism. Neurology (1983) 0.93
Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol (1979) 0.93
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain (2006) 0.92
Spin trapping of oxygen and carbon-centered free radicals in ischemic canine myocardium. Free Radic Biol Med (1987) 0.92
Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes (1990) 0.92
Possible explanation for loss of detectable antibody in patients with disseminated malignant melanoma. Nature (1971) 0.92
Human adverse reproductive outcomes and electromagnetic field exposures: review of epidemiologic studies. Environ Health Perspect (1993) 0.92
Analysis of recombinant cytokines in human body fluids by immunoaffinity capillary electrophoresis. Electrophoresis (1998) 0.92
Enhanced lysosomal phospholipid degradation and lysophospholipid production due to free radicals. Biochem Biophys Res Commun (1984) 0.91
Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b. Ann Neurol (1997) 0.91
The 2003 Carl A Moyer Award: real-time metabolic monitors, ischemia-reperfusion, titration endpoints, and ultraprecise burn resuscitation. J Burn Care Rehabil (2004) 0.91
Separation of two distinct tumor-associated antibodies in the serum of melanoma patients. J Natl Cancer Inst (1972) 0.91
Effects of growth at different temperatures on the physical state of lipids in native microsomal membranes from Tetrahymena. Biochemistry (1980) 0.90
Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus. Stroke (1988) 0.90
Update on topical cyclosporin A. Background, immunology, and pharmacology. Cornea (1990) 0.90
Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol (1990) 0.90
Ia antigens on indeterminate cells of the epidermis: immunoelectronmicroscopic studies of surface antigens. Br J Dermatol (1979) 0.90
Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiol (1997) 0.89
Characterization of the fertilization antigen 1 for the development of a contraceptive vaccine. Proc Natl Acad Sci U S A (1986) 0.88
Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int (1990) 0.88
Immune complexes in human melanoma: a consequence of deranged immune regulation. Scand J Immunol (1976) 0.88
Immune complex arthritis in a patient with Schistosoma mansoni infection. Arthritis Rheum (1986) 0.88
Lisuride in parkinsonism. Neurology (1981) 0.87
Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology (1992) 0.87
A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome. Ann N Y Acad Sci (1995) 0.86
Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition. Mol Cell Biochem (1997) 0.86
Central motor conduction time: reproducibility and discomfort of different methods. Muscle Nerve (1998) 0.85
Hyperimmunoglobulin E syndrome: response to transfer factor and ascorbic acid therapy. Clin Immunol Immunopathol (1979) 0.85